CSOFT Health Sciences announced its appointment of Vladimir Misik, PhD as Vice President of Global Clinical Strategy.
The Pistoia Alliance announced Becky Upton,PhD as its first female president.
Chris Schoonmaker has joined PHASTAR as Chief Operations Officer.
eClinical Solutions named Venu Mallarapu as their new Vice President of Strategy and Global Operations.
Saama Technologies, LLC announced that Vivek Sharma has joined the company as Chief Executive Officer.
Walgreens announced the hiring of the following: Kendal Whitlock as Head of Digital Optimization, Real World Evidence Clinical Trials; John Campbell as Head of Decentralized Clinical Trials; Liam Wood as Head of Product, Clinical Trials; and Adam Samson as Head of Clinical Delivery Operations, Clinical Trials.
Clario announced that Christopher Fikry, MD has begun his tenure as CEO.
Noel Alaka joined COTA, Inc. as Vice President of Life Sciences.
MMS Holdings has been selected by MAPS Public Benefit Corporation (MAPS PBC) as its CRO for the development of a New Drug Application for MDMA-assisted therapy for posttraumatic stress disorder.
HeartcoR Solutions announced it has relocated from Algonquin, IL to Schaumburg, IL.
Sharp has expanded its clinical services offering at its Heerenveen facility in the Netherlands.
SGS’s Quay Pharma will open its new pharmaceutical development and clinical manufacturing facility in Hudson, NH.
Emmes researchers contributed to a successful AIDS Malignancy Consortium study and the results were published in the New England Journal of Medicine.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.